Summary & Overview
Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses with CC: Inpatient Reimbursement Overview
DRG 844 groups admissions for other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with a Complication or Comorbidity, encompassing hematologic and oncologic clinical management that increases inpatient resource use. Proper coding and documentation matter for inpatient reimbursement because the Complication or Comorbidity status affects the Diagnosis-Related Group assignment and resulting Medicare payment.
DRG 844 Overview
DRG 844 covers hospital admissions for other myeloproliferative disorders or poorly differentiated neoplastic diagnoses when a Complication or Comorbidity is present. These cases typically involve hematology and oncology evaluation, often requiring transfusions, cytoreductive therapy, or management of disease-related complications. This Diagnosis-Related Group matters for Medicare payment because the presence of a Complication or Comorbidity adjusts relative resource use and hospital reimbursement under inpatient prospective payment. Accurate clinical documentation and coding determine assignment to this Diagnosis-Related Group and the associated payment weight.